Lantern Pharma (LTRN) Q1 2025 Earnings Transcript

Image source: The Motley Fool.

Date

Thursday, March 27, 2025 astatine 4:30 p.m. ET

Call participants

• President and CEO — Panna Sharma

• Chief Financial Officer — David Margrave

Need a punctuation from a Motley Fool analyst? Email [email protected]

Full Conference Call Transcript

Operator: Good morning, and invited to our First Quarter 2025 Earnings Call. As a reminder, this telephone is being recorded, and each attendees are successful a listen-only mode. We volition unfastened the telephone for questions-and-answers aft our management's presentation. A webcast replay of today's league telephone volition beryllium disposable connected our website astatine lanternpharma.com. soon aft the call. We issued a property merchandise earlier the marketplace opened today, summarizing our fiscal results and advancement crossed the institution for the archetypal 4th ended March 31, 2025. A transcript of this merchandise is disposable done our website astatine lanternpharma.com, wherever you volition besides find a nexus to the slides absorption volition beryllium referencing connected today's call.

We would similar to punctual everyone that remarks astir aboriginal expectations, performance, estimates, and prospects represent forward-looking statements for purposes of harmless harbor provisions nether the Private Securities Litigation Reform Act of 1995. Lantern Pharma cautions that these forward-looking statements are taxable to risks and uncertainties that whitethorn origin existent results to disagree materially from those anticipated. A fig of factors could origin existent results to disagree materially from those indicated by forward-looking statements, including results of objective trials and the interaction of competition.

Additional accusation concerning factors that could origin existent results to disagree materially from those successful the forward-looking statements tin beryllium recovered successful our yearly study connected Form 10-K for the twelvemonth ended December 31, 2024, which is connected record with the SEC and disposable connected our website. Forward-looking statements made connected this league telephone are arsenic of today, May 15, 2025, and Lantern Pharma does not mean to update immoderate of these forward-looking statements to bespeak events from circumstances that hap aft contiguous unless required by law. The webcast replay of the league telephone and webinar volition beryllium disposable connected Lantern's website. On today's webcast, we person Lantern Pharma’s CEO, Panna Sharma, and CFO, David Margrave.

Panna volition commencement things disconnected with introductions and an overview of Lantern's strategy and concern exemplary and item caller achievements successful our operations. After which, David volition sermon our fiscal results. This volition beryllium followed by immoderate concluding comments from Panna, and past we'll unfastened the telephone for Q&A. I'd present similar to crook the telephone implicit to Panna Sharma, President and CEO of Lantern Pharma. Panna, delight spell ahead.